Table 2.

Factors to Be Considered in Determining Whether the New Standard of HCV Therapy Should Be Initiated

Host factors: race, age, medical comorbidities, drug interactions, psychosocial circumstances, motivation, ability to adhere to a complex treatment regimen, and IL‐28B genotype

Disease factor: fibrosis stage

Treatment factor: IFN‐naive versus IFN‐experienced